ELISA Kit for Fibronectin Type III Domain Containing Protein 5 (FNDC5)
SEN576HU
Product group Assays
Overview
- SupplierCloud-Clone Corp.
- Product NameELISA Kit for Fibronectin Type III Domain Containing Protein 5 (FNDC5)
- Delivery Days Customer12
- Assay Detection Range15.6-1,000pg/mL
- Assay PrecisionIntra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Fibronectin Type III Domain Containing Protein 5 (FNDC5) were tested 20 times on one plate, respectively. Inter-assay Precision (Precision between assays): ...
- Assay SensitivityThe minimum detectable dose of this kit is typically less than 6.9pg/mL
- Assay SpecificityThis assay has high sensitivity and excellent specificity for detection of Fibronectin Type III Domain Containing Protein 5 (FNDC5). No significant cross-reactivity or interference between Fibronectin Type III Domain Containing Protein 5 (FNDC5) and analo
- Assay Test PrincipleThe test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Fibronectin Type III Domain Containing Protein 5 (FNDC5). Standards or samples are then ...
- Assay Time3h
- CertificationResearch Use Only
- UNSPSC41116158
References
- Pattern of Adiponectin, Osteocalcin, Irisin, FGF-21, and MCP-1 According to the Body Size Phenotype: Could They Be Markers of Metabolic Health in Mexican-Mestizo Middle-Aged Women? Balcazar-Hernandez L et al., 2021 Nov 11, MetabolitesRead more
- Salivary irisin: potential inflammatory biomarker in recurrent apthous stomatitis patients. Altay DU et al., 2021 Mar, Eur Rev Med Pharmacol SciRead more
- The Diagnostic Value of FNDC5/Irisin in Renal Cell Cancer. Altay DU et al., 2018 Jul-Aug, Int Braz J UrolRead more
- Irisin stimulates cell proliferation and invasion by targeting the PI3K/AKT pathway in human hepatocellular carcinoma. Shi G et al., 2017 Nov 4, Biochem Biophys Res CommunRead more
- Physiology and role of irisin in glucose homeostasis. Perakakis N et al., 2017 Jun, Nat Rev EndocrinolRead more
- Lower Circulating Irisin Level in Patients with Diabetes Mellitus: A Systematic Review and Meta-Analysis. Du XL et al., 2016 Sep, Horm Metab ResRead more
- Maternal circulating levels of irisin in intrahepatic cholestasis of pregnancy. Kirbas A et al., 2016 Nov, J Matern Fetal Neonatal MedRead more
- Lower irisin level in patients with type 2 diabetes mellitus: A case-control study and meta-analysis. Zhang C et al., 2016 Jan, J DiabetesRead more
- Leptin administration activates irisin-induced myogenesis via nitric oxide-dependent mechanisms, but reduces its effect on subcutaneous fat browning in mice. Rodriguez A et al., 2015 Mar, Int J Obes (Lond)Read more
- Inconsistency in circulating irisin levels: what is really happening? Sanchis-Gomar F et al., 2014 Jul, Horm Metab ResRead more